US Patent Issued to Merck Sharpe & Dohme on March 3 for "Formulations of anti-RSV antibodies and methods of use thereof" (New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,526, issued on March 3, was assigned to Merck Sharpe & Dohme LLC (Rahway, N.J.).

"Formulations of anti-RSV antibodies and methods of use thereof" was invented by Venus Hashemi (Manalapan, N.J.), Arnab De (Burlington, Mass.) and Chakravarthy Nachu Narasimhan (Scotch Plains, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to stable formulations comprising antibodies or antigen-binding fragments thereof that bind to respiratory syncytial virus (RSV). Also provided are methods of preventing and/or treating RSV-related diseases with the formulations of the invention."

The patent was filed on Oct. 14, 2019, under Applica...